Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy.

Saved in:
Bibliographic Details
Title: Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy.
Authors: Ghasemi A; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland., Martinez-Usatorre A; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland., Li L; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland., Hicham M; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland., Guichard A; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland., Marcone R; Agora Cancer Research Center, Lausanne, Switzerland.; Translational Data Science (TDS) Facility, Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Fournier N; Agora Cancer Research Center, Lausanne, Switzerland.; Translational Data Science (TDS) Facility, Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Torchia B; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland., Martinez Bedoya D; Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland.; Center for Translational Research in Onco-Hematology, University of Geneva (UNIGE), Geneva, Switzerland., Davanture S; Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland.; Center for Translational Research in Onco-Hematology, University of Geneva (UNIGE), Geneva, Switzerland., Fernández-Vaquero M; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Fan C; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Janzen J; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Mohammadzadeh Y; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland., Genolet R; Ludwig Institute for Cancer Research, Lausanne, Switzerland.; Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Lausanne, Switzerland., Mansouri N; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland., Wenes M; Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland.; Center for Translational Research in Onco-Hematology, University of Geneva (UNIGE), Geneva, Switzerland., Migliorini D; Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland.; Center for Translational Research in Onco-Hematology, University of Geneva (UNIGE), Geneva, Switzerland.; Department of Oncology, Geneva University Hospital (HUG), Geneva, Switzerland., Heikenwalder M; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; The M3 Research Center, Eberhard Karls University, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180), Eberhard Karls University, Tübingen, Germany., De Palma M; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), Lausanne, Switzerland. michele.depalma@epfl.ch.; Agora Cancer Research Center, Lausanne, Switzerland. michele.depalma@epfl.ch.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland. michele.depalma@epfl.ch.
Source: Nature cancer [Nat Cancer] 2024 Feb; Vol. 5 (2), pp. 240-261. Date of Electronic Publication: 2023 Nov 23.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2662-1347
DOI:10.1038/s43018-023-00668-y